戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 -2 (H-2k) (bm1) or F1 (B6 x bm1) mice before skin transplantation.
2 with an emphasis on cell-based therapies and skin transplantation.
3 ited number of lymphatic capillaries through skin transplantation.
4 ent inflammatory process in a mouse model of skin transplantation.
5 CD154 antibody following allogeneic islet or skin transplantation.
6  important in initiating rejection in murine skin transplantation.
7 reg expansion by mIL-2 in 2 murine models of skin transplantation.
8  to prolong allograft survival in a model of skin transplantation.
9  in rhesus macaques sensitized by sequential skin transplantations.
10 with thromboembolism risk) in the context of skin transplantation 2 years before the angiography stud
11 ntation with LN excision (n = 6), allogeneic skin transplantation alone (n = 6), or syngeneic skin tr
12 ishing mixed chimerism was tested in vivo by skin transplantation and in vitro by mixed leukocyte rea
13                 Mice treated with allogeneic skin transplantation and LN excision had lower expressio
14 F rats were presensitized to ACI antigens by skin transplantation and received heterotopic osteomyocu
15    These T cells proliferated modestly after skin transplantation and underwent relatively weak funct
16  relative benefits and limitations of murine skin transplantation as a model of alloreactivity.
17                    To study host response to skin transplantation, C57BL/6 mice underwent allogeneic
18      Using a mouse model of minor-mismatched skin transplantation, coupled with the tracking of 2 ski
19  of WF spleen cells (2x10[7]) at the time of skin transplantation (day -7) abrogated <24-hr rejection
20 clinically relevant humanised mouse model of skin transplantation, expBreg prolongs human allograft s
21 stinct antigenic hierarchy between heart and skin transplantation: H60-specific CD8(+) T cells were t
22 ases allograft survival in a murine model of skin transplantation in fully mismatched strain combinat
23                                    Secondary skin transplantation in long-term acceptors of islet all
24 of P2X7Rs on EV release by donor cells after skin transplantation in mice.
25 and CD8(+) memory T cell alloresponses after skin transplantation in wild-type mice.
26          Furthermore, in this mouse model of skin transplantation, increased induction of allospecifi
27 espite this difference in outcome, heart and skin transplantation induced antidonor T cell responses
28  phase of allograft rejection in a humanized skin transplantation model in mice reconstituted with hu
29                       In a sensitized rodent skin transplantation model, A-START only demands 240 mic
30                                      Using a skin transplantation model, we found that perforin-defic
31 e ATDCs for their therapeutic potential in a skin transplantation model.
32 ism induction and graft tolerance in a mouse skin transplantation model.
33 can delay allograft rejection in a humanized skin transplantation model.
34 tion in fully MHC-mismatched rat cardiac and skin transplantation models.
35  transplantation alone (n = 6), or syngeneic skin transplantation (n = 4).
36                                   Allogeneic skin transplantation remains a rigorous test of any immu
37                          Although autologous skin transplantation remains the most common form of tre
38                    Following murine heart or skin transplantation, scaffold implants accumulate predo
39  solution to these problems, but traditional skin transplantation techniques cause substantial morbid
40     The authors demonstrated that, following skin transplantation, the donor mast cell-mediated senes
41 keletal muscle combined with glabrous dermal skin transplantation, thus forming a bi-directional comm
42 used a mouse model of MHC-class I mismatched skin transplantation to investigate the contribution of
43         We demonstrate that, initially after skin transplantation, Treg attenuate the priming of dono
44  compounds, and a murine model of allogeneic skin transplantation was adopted to assess the in vivo e
45 lantation, C57BL/6 mice underwent allogeneic skin transplantation with LN excision (n = 6), allogenei
46                                              Skin transplantation with third-party CBA, host BALB/c a
47                             After kidney and skin transplantation, xenografts were rejected after 8-2